UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

The Lancet (British edition), 2002-07, Vol.360 (9327), p.109-113

2002

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description

BMC cardiovascular disorders, 2012-05, Vol.12 (1), p.33-33, Article 33

2012

Link zum Volltext

Verfügbarkeit prüfen

Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

Trials, 2012-01, Vol.13 (1), p.1-1, Article 1

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

European heart journal, 2015-05, Vol.36 (20), p.1264-1272

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial registration: looking back and moving ahead

The Lancet (British edition), 2007-06, Vol.369 (9577), p.1909-1911

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trial Registration — Looking Back and Moving Ahead

The New England journal of medicine, 2007-06, Vol.356 (26), p.2734-2736

2007

Link zum Volltext

Verfügbarkeit prüfen

Can we pull the plug on warfarin in atrial fibrillation?

The Lancet (British edition), 2003-11, Vol.362 (9397), p.1686-1687

Verheugt, Freek WA

2003

Link zum Volltext

Verfügbarkeit prüfen

The Role of the Cardiologist in the Primary Prevention of Cardiovascular Disease With Aspirin

Journal of the American College of Cardiology, 2015-01, Vol.65 (2), p.122-124

Verheugt, Freek W.A., MD

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

The Lancet (British edition), 2004-08, Vol.364 (9435), p.675-684

2004

Link zum Volltext

Verfügbarkeit prüfen

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial

The American heart journal, 2015-10, Vol.170 (4), p.683-694.e3

2015

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Journal of the American College of Cardiology, 2007-06, Vol.49 (23), p.2249-2255

2007

Link zum Volltext

Verfügbarkeit prüfen

Managing Antithrombotic Therapy in Patients With Both Atrial Fibrillation and Coronary Heart Disease

Clinical therapeutics, 2014-09, Vol.36 (9), p.1176-1181

2014

Link zum Volltext

Verfügbarkeit prüfen

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2017-02, Vol.103 (4), p.293

2017

Link zum Volltext

Verfügbarkeit prüfen

Routine Angioplasty after Fibrinolysis — How Early Should “Early” Be?

The New England journal of medicine, 2009-06, Vol.360 (26), p.2779-2781

Verheugt, Freek W.A

2009

Link zum Volltext

Verfügbarkeit prüfen

Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?

The American heart journal, 2012-04, Vol.163 (4), p.531-534

Verheugt, Freek W.A., MD, FACC, FESC

2012

Link zum Volltext

Verfügbarkeit prüfen

Low Body Weight and Prescribing DOACs in Atrial Fibrillation

Journal of the American College of Cardiology, 2019-03, Vol.73 (8), p.932-934

Verheugt, Freek W.A.

2019

Link zum Volltext

Verfügbarkeit prüfen

Who is ineligible for warfarin in atrial fibrillation?

The Lancet (British edition), 2009-08, Vol.374 (9689), p.510-511

Verheugt, Freek WA

2009

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)

Journal of the American College of Cardiology, 2019-08, Vol.74 (5), p.699-711

2019

Link zum Volltext

Verfügbarkeit prüfen

Who is to blame?

The Lancet (British edition), 2002-09, Vol.360 (9335), p.789-789

Verheugt, Freek WA

2002

Link zum Volltext

Verfügbarkeit prüfen

Antiplatelet therapy and anticoagulants – Authors' reply

The Lancet (British edition), 2013-07, Vol.382 (9886), p.25-25

2013

Link zum Volltext

Verfügbarkeit prüfen

Good old warfarin for stroke prevention in atrial fibrillation

The Lancet (British edition), 2006-06, Vol.367 (9526), p.1877-1878

Verheugt, Freek WA

2006

Link zum Volltext

Verfügbarkeit prüfen

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

European heart journal. Acute cardiovascular care, 2019-12, Vol.8 (8), p.745-754

2019

Link zum Volltext

Verfügbarkeit prüfen

Timing of angiography after fibrinolysis for ST-elevation acute myocardial infarction

Current opinion in cardiology, 2010-07, Vol.25 (4), p.302-304

Verheugt, Freek WA

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction

Journal of the American College of Cardiology, 2002-06, Vol.39 (11), p.1733-1737

2002

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulants in heart disease: current status and perspectives

European heart journal, 2007-04, Vol.28 (7), p.880-913

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaHeart

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(49)
Science & Technology
(49)
Humans
(48)
Cardiac & Cardiovascular Systems
(25)
Cardiovascular System & Cardiology
(25)
Male
(25)
Female
(23)
Heart Attacks
(20)
Middle Aged
(20)
Aged
(18)
General & Internal Medicine
(17)
Medicine, General & Internal
(17)
Cardiovascular Disease
(16)
Cardiology
(15)
Aspirin
(13)
Aspirin - Therapeutic Use
(11)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Anticoagulants - Therapeutic Use
(10)
Platelet Aggregation Inhibitors - Therapeutic Use
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description

Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Clinical trial registration: looking back and moving ahead

Clinical Trial Registration — Looking Back and Moving Ahead

Can we pull the plug on warfarin in atrial fibrillation?

The Role of the Cardiologist in the Primary Prevention of Cardiovascular Disease With Aspirin

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Managing Antithrombotic Therapy in Patients With Both Atrial Fibrillation and Coronary Heart Disease

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Routine Angioplasty after Fibrinolysis — How Early Should “Early” Be?

Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?

Low Body Weight and Prescribing DOACs in Atrial Fibrillation

Who is ineligible for warfarin in atrial fibrillation?

Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)

Who is to blame?

Antiplatelet therapy and anticoagulants – Authors' reply

Good old warfarin for stroke prevention in atrial fibrillation

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Timing of angiography after fibrinolysis for ST-elevation acute myocardial infarction

Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction

Anticoagulants in heart disease: current status and perspectives

Aktive Filter

Suchergebnisse filtern